FDA plans fast review of 3 psychedelic drugs following Trump directive
President Trump signed an executive order directing the FDA and other federal agencies to speed access and loosen restrictions on psychedelics.
- US FDA plans ultra-fast review of 3 psychedelic drugs after Trump directive South China Morning Post —
- FDA grants quick review for 3 psychedelic drug trials NBC News —
- FDA fast-tracks psychedelic drug research following Trump executive order CNBC —
- US FDA moves to fast-track psychedelic drugs after Trump order - Reuters Reuters —
- U.S. FDA plans ultra-fast review of three psychedelic drugs following Trump directive CTV News —